ACROBiosystems Hits Day High with Strong 5.31% Intraday Surge

ACROBiosystems Co., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has shown significant activity today, gaining 5.31% on July 10, 2026. The stock reached an intraday high of CNY 52.30, marking a notable performance against the backdrop of a declining China Shanghai Composite, which fell by 1.0% on the same day. Over the past month, ACROBiosystems has demonstrated a robust increase of 34.75%, contrasting sharply with the composite index's minimal growth of 0.07%. However, the stock's one-year performance remains challenging, with a decline of 26.02%, significantly underperforming the market, which has seen a return of 13.86% during the same period. Financially, ACROBiosystems reported a strong operating cash flow of CNY 530.69 million, alongside a notable debtors turnover ratio of 7.94 times. Despite these positive indicators, the company has faced long-term growth hurdles, with net sales growing at an annual rate of 21.30% and an operating profit decline of 0.99% over the last five years. The stock's return on equity stands at 6.17%, with a price-to-book ratio of 1.71, reflecting a fair valuation in the current market landscape.